Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 160.5 | 62 | |
RA2159 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 102.0 | 47 | |
RA2159 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 131.5 | 70 | |
RA2159 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 117.0 | 77 | |
N2586 | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 120.5 | 56 | ||||
N2586 | PD184352 | 0.1 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 138.0 | 39 | |
N2586 | Lestaurtinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 124.0 | 55 | |
N2586 | Ruxolitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 130.0 | 37 | |
N2586 | Tofacitinib | 0.3 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 119.0 | 49 | |
N2586 | IKK16 | 2.0 | uM | Adiponectin | 5 | ng/mL | 1 | GM-CSF | 186.0 | 47 | |
RA2159 | Leptin | 1 | ng/mL | 1 | GM-CSF | 259.5 | 64 | ||||
RA2159 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 281.0 | 54 | |
RA2159 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 239.0 | 59 | |
RA2159 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 238.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 240.0 | 57 | |
RA2159 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 234.0 | 56 | |
N2586 | Leptin | 1 | ng/mL | 1 | GM-CSF | 229.5 | 36 | ||||
N2586 | PD184352 | 0.1 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 215.5 | 46 | |
N2586 | Lestaurtinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 234.0 | 77 | |
N2586 | Ruxolitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 215.0 | 69 | |
N2586 | Tofacitinib | 0.3 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 223.5 | 34 | |
N2586 | IKK16 | 2.0 | uM | Leptin | 1 | ng/mL | 1 | GM-CSF | 231.5 | 32 | |
RA2159 | 1 | GM-CSF | 243.0 | 64 | |||||||
RA2159 | PD184352 | 0.1 | uM | 1 | GM-CSF | 275.0 | 71 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 1 | GM-CSF | 256.0 | 69 |